Select your Market

Global
Global
CAREERS

Life Science

Researchers need state-of-the-art tools, services and expertise to perform experiments and engineer new products. That’s where we come in.

Together, for Life. With Science.

Our customers from Academia, Pharma and Biotech around the world rely on our tools, services and expertise to do their best science. We offer them one of the broadest portfolios in the industry. Plus, our presence extends well beyond labs: our innovations touch individuals around the world.

Explore Our Offerings

Science is everywhere.
So Are We.

Science starts with us – and continues with you. Because science is everywhere, and so are our customers. From bench to the boardroom and everywhere in between, you’re working to deliver the next scientific breakthrough. And we’re there for every step of your journey.

Expertise

Whether you are a researcher from a small lab or an engineer running massive operations, our tools, services and digital platforms empower you to work more effectively - from discovery to commercialization. Our business include:

Life Science by the Numbers

  • 50+

    Manufacturing and Testing Sites

  • 60+

    Distribution Centers

  • 26K+

    Employees

  • 300K+

    Products

    PRESS RELEASES

    1. Merck KGaA, Darmstadt, Germany, Delivers Solid Q3 2026 Results and Advances ...

      Performance was driven by Process Solutions, Rare Diseases and Semiconductor Solutions, in line with the company’s focus on high growth value drivers.

    2. FDA Approves PIMJETMI® (pimicotinib) for Patients with Tenosynovial Giant Cell ...

      EMD Serono announced today that the U.S. FDA has approved PIMJETMI (pimicotinib) as a systemic treatment for patients with symptomatic TGCT.

    3. Merck KGaA, Darmstadt, Germany, to Divest CDMO Business to Lonza

      The company has signed a definitive agreement to divest its contract development and manufacturing organization (CDMO) business to Lonza.

    4. MilliporeSigma Opens €300 Million Asia-Pacific Bioprocessing Center in Daejeon ...

      MilliporeSigma opened a €300 million Daejeon center, expanding regional capacity and access to critical bioprocessing materials.